Cost-effectiveness of routine coronary angiography after acute myocardial infarction

Circulation

Volumn 94, Issue 5, 1996, Pages 957-965

  Kuntz, Karen M ^a,b   Tsevat, Joel ^c   Goldman, Lee ^a,b,d   Weinstein, Milton C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

angiography; coronary disease; cost effectiveness analysis

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EXERCISE TOLERANCE; HEALTH CARE QUALITY; HOSPITALIZATION; LIFE EXPECTANCY; MEDICARE; PRIORITY JOURNAL;

EID: 0029835159     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.957     Document Type: Article

References (55)

1. Pasternak RC, Braunwald E. Acute myocardial infarction. In: Harrison's Principles of Internal Medicine. 12th Ed. New York, NY: McGraw-Hill; 1991:953.
2. American College of Cardiology/American Heart Association Joint Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Angiography). Guidelines for coronary angiography. J Am Coll Cardiol. 1987;10:935-950, and Circulation. 1987;76:963A-977A.
3. American College of Cardiology/American Heart Association Joint Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Angiography). Guidelines for coronary angiography. J Am Coll Cardiol. 1987;10:935-950, and Circulation. 1987;76:963A-977A.
4. Bernstein SJ, Laouri M, Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH. Coronary Angiography: A Literature Review and Ratings of Appropriateness and Necessity. Santa Monica, Calif: RAND Corp; 1992, publication No. JRA-03.
5. Williams DO, Braunwald E, Knatternd G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R, and TIMI Investigators. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II Trial. Circulation. 1992;85:533-542.
6. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E, for the TIMI IIIB Investigators. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643-1650.
7. Hlatky MA, Cotugno HE, Mark DB, O'Connor C, Califf RM, Pryor DB. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol. 1988;61:515-518.
8. Dittus RS, Roberts SD, Adolph RJ. Cost-effectiveness analysis of patient management alternatives after uncomplicated myocardial infarction: a model. J Am Coll Cardiol. 1987;10:869-878.
9. Patterson RE, Horowitz SF, Eng C, Meller J, Goldsmith SJ, Pichard AD, Halgash DA, Herman MV, Gorlin R. Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction? Am J Cardiol. 1983;51:361-372.
10. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983;3:419-458.
11. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao X, for the Emory Angioplasty versus Surgery Trial (EAST). A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044-1050.
12. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 1994;331:1037-1043.
13. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MIS, Palacious IF, on behalf of the ERACI Group. Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol. 1993;22:1060-1067.
14. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341:573-580.
15. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, Morris C, Mathur V, Varnauskas E, Chalmers TC. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570.
16. Topol EJ, Holmes DR, Rogers WJ. Coronary angiography after thrombolytic therapy for acute myocardial infarction. Ann Intern Med. 1991;114:877-885.
17. Rogers WJ, Babb JD, Baim DS, Chesebro JH, Gore JM, Roberts R, Williams DO, Frederick M, Passamani ER, Braunwald E, for the TIMI II Investigators. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. J Am Coll Cardiol. 1991;17:1007-1016.
18. Weiner DA, McCabe C, Klein MD, Ryan TJ. ST segment changes post-infarction: predictive value for multivessel coronary disease and left ventricular aneurysm. Circulation. 1978;58:887-891.
19. De Feyter PJ, van Eenige MJ, Dighton DH, Visser FC, de Jong J, Roos JP. Prognostic value of exercise testing, coronary angiography and left ventriculography 6-8 weeks after myocardial infarction. Circulation. 1982;66:527-536.
20. Peart I, Seth L, Albers C, Odemuyiwa O, Hall RJC. Post-infarction exercise testing in patients under 55 years: relation between ischaemic abnormalities and the extent of coronary artery disease. Br Heart J. 1986;55:67-74.
21. Murray DP, Tan LB, Salih M, Weissberg P, Murray RG, Littler WA. Does β adrenergic blockade influence the prognostic implications of post-myocardial infarction exercise testing? Br Heart J. 1988;60:474-479.
22. Miranda CP, Lehmann KG, Lachterman B, Coodley EM, Froelicher VF. Comparison of silent and symptomatic ischemia during exercise testing in men. Ann Intern Med. 1991;114:649-656.
23. Sanz G, Castaner A, Betriu A, Magrina J, Roig E, Coll S, Pare JC, Navarro-Lopez F. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982;306:1065-1070.
24. Roubin GS, Harris PJ, Bernstein L, Kelly DT. Coronary anatomy and prognosis after myocardial infarction in patients 60 years of age and younger. Circulation. 1983;67:743-749.
25. Schulman SP, Achuff SC, Griffith LSC, Humphries JO, Taylor GJ, Mellits ED, Kennedy M, Baumgartner R, Weisfeldt ML, Baughman KL. Prognostic cardiac catheterization variables in survivors of acute myocardial infarction: a five year prospective study. J Am Coll Cardiol. 1988;11:1164-1172.
26. Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, Noto TJ. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions, I: results and complications. Cathet Cardiovasc Diagn. 1989;17:5-10.
27. Lozner EC, Johnson LW, Johnson S, Krone R, Pichard AD, Vetrovec GW, Nota TJ. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions, II: an analysis of 218 deaths related to coronary arteriography. Cathet Cardiovasc Diagn. 1989;17:11-14.
28. Davis K, Kennedy JW, Kemp HG, Judkins MP, Gosselin AJ, Killip T. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation. 1979;59:1105-1112.
29. Holmes DR, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, Williams DO, Cowley MJ, Faxon DP, Kent KM, Bentivoglio LG, Detre K. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1988;12:1149-1155.
30. Kelsey SF, Miller DP, Holubkov R, Lu AS, Cowley MJ, Faxon DP, Detre KM. Results of percutaneous transluminal coronary angioplasty in patients ≥65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry). Am J Cardiol. 1990;66:1033-1038.
31. Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State: an analysis of risk factors and hospital mortality rates. JAMA. 1990;264:2768-2774.
32. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Tryzelaar JF, Hernandez F, Adrian L, Casey KJ, Soule DN, Marrin CAS, Nugent WC, Charlesworth DC, Clough R, Katz S, Leavitt BJ, Wennberg JE, for the Northern New England Cardiovascular Disease Study Group. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. JAMA. 1991;266:803-809.
33. Alder DS, Goldman L, O'Neil A, Cook EF, Mudge GH, Shemin RJ, DiSesa V, Cohn LH, Collins JJ. Long-term survival of more than 2000 patients after coronary artery bypass grafting. Am J Cardiol. 1986;58:195-202.
34. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the coronary heart disease policy model. Am J Public Health. 1987;77:1417-1426.
35. National Center for Health Statistics. Advance report of final mortality statistics: 1988. Monthly Vital Stat Rep. 1990;39.
36. Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK, Braunwald E, and the MILIS Study Group. Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients. Am J Cardiol. 1988;62:860-867.
37. Sanz G, Betriu A, Castaner A, Roig E, Heras M, Magrina J, Pare C, Navarro-Lopez F. Predictors of non-fatal ischemic events after myocardial infarction. Int J Cardiol 1988;20:73-86.
38. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender of mortality and prognostic variables. Am J Cardiol. 1988;62:1-7.
39. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina: analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med. 1990;113:852-871.
40. CASS Principal Investigators and Their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery - survival data. Circulation. 1983;68:939-950.
41. CASS Principal Investigators and Their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951-960.
42. Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolnitzky LM, Bigger JT, for the Multicenter Diltiazem Post-Infarction Research Group. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. J Am Coll Cardiol 1990;16:1327-1332.
43. Dudley RA, Harrell FE Jr, Smith R, Mark DB, Califf RM, Pryor DB, Glower D, Lipscomb J, Hlatky M. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol. 1993;46:261-271.
44. Hemenway D, Sherman H, Mudge GH Jr, Flatley M, Lindsey NM, Goldman L. Comparative costs versus symptomatic and employment benefits of medical and surgical treatment of stable angina pectoris. Med Care. 1985;23:133-141.
45. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
46. Taylor GJ, Humphries JO, Mellits ED, Pitt B, Schulze RA, Griffith LSC, Achuff SC. Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation. 1980;62:960-970.
47. Epstein SE, Palmeri ST, Patterson RE. Evaluation of patients after acute myocardial infarction: indications for cardiac catheterization and surgical intervention. N Engl J Med. 1982:307:1487-1492.
48. DeBusk RF, Blomqvist CG, Kouchoukos NT, Luepker RV, Miller HS, Moss AJ, Pollock ML, Reeves TJ, Selvester RH, Stason WB, Wagner GS, Willman VL. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med. 1986;314:161-166.
49. Goldman L, Sia STB, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med. 1988;319:152-157.
50. Tsevat J, Duke D, Goldman L, Pfeffer MA, Lamas GA, Soukup JR, Kuntz KM, Lee TH. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol. 1995;26:914-919.
51. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265:1145-1151.
52. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:408-413.
53. Ross J Jr, Gilpin EA, Madsen EB, Henning H, Nicod P, Dittrich H, Engler R, Rittelmeyer J, Smith SC, Viquerat C. A decision scheme for coronary angiography after acute myocardial infarction. Circulation. 1989;79:292-303.
54. Cohn PF. Silent myocardial ischemia: classification, prevalence, and prognosis. Am J Med. 1985;79(suppl 3A):2-6.
55. Califf RM, Harrell FE Jr, Lee KL. Rankin JS, Hlatky MA, Mark DB, Jones RH. Muhlbaier LH, Oldham HN, Pryor DB. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA. 1989;261:2077-2086.